More on CRNX

- Summary
- Chart
- Profile
- Historical

Data

- Earnings (+7.3% Growth)
- Ratings (3.7 Score)
- Holders

Upcoming Events

- Earnings (11/6/26 *Est.)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Crinetics Pharmaceuticals (NQ:CRNX)
Delayed: 84.08 --0 (-0%)
Prev. Close $84.08  
Open$84.08 
52 Wk High$ 
52 Wk Low$ 
Day High$84.08 
Day Low$84.08 
P/E N/A  
EPS$ 
Volume3,377 

Friends, Peers and Foes (?): VRTX, PRAX, CYTK, MDGL, NAMS (more...)

Aug 7, 2026 11:05 AM Form SCHEDULE 13G/A Crinetics Pharmaceutical Filed by: FMR LLC
Aug 3, 2026 04:43 PM Crinetics Pharmaceuticals (CRNX) Tops Q2 EPS by 8c
Aug 3, 2026 04:13 PM Form 10-Q Crinetics Pharmaceutical For: Jun 30
Aug 3, 2026 04:09 PM Form 8-K Crinetics Pharmaceutical For: Aug 03
Aug 3, 2026 04:05 PM Crinetics Pharmaceuticals Reports Second Quarter 2026 Financial Results and Provides Business Update
Aug 3, 2026 08:29 AM Form SCHEDULE 13G/A Crinetics Pharmaceutical Filed by: FARALLON CAPITAL MANAGEMENT, L.L.C.
Jul 31, 2026 04:17 PM Form DEFM14A Crinetics Pharmaceutical
Jul 28, 2026 02:38 AM UBS Downgrades Crinetics (CRNX) to Neutral
Jul 21, 2026 04:31 PM Form PREM14A Crinetics Pharmaceutical For: Jul 21
Jul 21, 2026 07:38 AM Shareholder Alert: Ademi LLP investigates whether Crinetics Pharmaceuticals, Inc. is obtaining a Fair Price for Public Shareholders
View All Articles

Entities mentioned with CRNX

View All Entities